Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV
This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01166126
First received: July 12, 2010
Last updated: January 4, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |